1849 Bio achieved important milestones across funding, partnerships, and technical development in 2025. The company secured a $900K grant from the South Korean government, accelerating its R&D efforts and enabling the expansion of operations into Korea. There, 1849 Bio began advancing applications in e-waste processing, adapting its bioleaching platform to recover valuable metals from electronic waste. The company also signed an exclusive option agreement with Columbia University for novel IP related to high-performance microbes, strengthening its technological edge.

On the technical front, 1849 Bio continued refining its microbe isolation and engineering pipeline, successfully identifying new strains with enhanced tolerance to challenging mining conditions and demonstrating early proof-of-concept improvements through genetic modifications. In collaboration with the University of Maryland, the team advanced its miniature column prototypes—an important step toward replicating real-world mining conditions at lower cost and higher speed, enabling faster iteration and validation of its technology.

Looking ahead, the main challenge remains defining the fastest path to market in a traditionally conservative industry. While adoption in mining can be slow, successful first deployments often unlock rapid scaling. With growing global demand for critical minerals and increasing interest in innovative extraction technologies, 1849 Bio is positioning itself to turn technical breakthroughs into commercial momentum.